Lunit to Showcase 9 AI-based Research Results at ESMO 2023
- Written by PR Newswire
![]() |
- 9 abstracts accepted by the ESMO annual meeting - unveiling insights into cancer analysis, immunotherapy response, and predictive biomarkers at ESMO 2023
SEOUL, South Korea, Oct. 10, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of 9...
Read more: Lunit to Showcase 9 AI-based Research Results at ESMO 2023